Milnacipran Pierre Fabre Medicament (milnacipran)
- Region
- 🇪🇺 EU
- Active substance
- milnacipran
- Company
- Pierre Fabre Medicament
- Status
- Refused
- Therapeutic area
- Fibromyalgia
- CHMP opinion
- Thu 19 Nov 2009
- Application
- EMEA/H/C/001034
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Impulsor Refused · Pierre Fabre Medicament
Follow Milnacipran Pierre Fabre Medicament
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.